LOEWS CORP
Institutional investor · Portfolio as of Q4 2023
SEC EDGAR SourceSEC Filings
LOEWS CORP manages $10.8B across 18 positions as of Q4 2023. Top holdings: CNA (97.2%), HBI (0.7%), BERY (0.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3/5.0.
Q4 2023 Summary
Active quarter - 2 new positions, 8 exits, 7 increased. Top move: HBI (INCREASED, conviction 70). Portfolio: $10.8B across 18 positions.
Top holdings by portfolio weight
CNA97.20%
HBI0.68%
BERY0.25%
INGR0.20%
LYB0.20%
ALLY0.19%
APO0.17%
META0.16%
HCA0.16%
GS0.13%
Other0.13%
Portfolio allocation by GICS sector
Financial Services97.70%
Unknown0.93%
Basic Materials0.34%
Communication Services0.32%
Healthcare0.24%
Consumer Defensive0.20%
Consumer Cyclical0.11%
Energy0.10%
Technology0.06%
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Upgrade to Pro to see the worst-performing positions.
View plansCost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Top Holdings18 positions
Activity:
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction | |
|---|---|---|---|---|---|---|---|---|
CNA FINANCIAL CORP | 248.4M | $10.5B | 97.2% | $27.27 | +32.04% | 20 qtrssince 2019-Q1 | Unchanged 0 | |
HANESBRANDS INC | 16.5M | $73.6M | 0.7% | — | — | 4 qtrssince 2023-Q1 | Increased 70 | |
BERRY GLOBAL GROUP INC | 406,000 | $27.4M | 0.3% | — | — | 18 qtrssince 2019-Q3 | Unchanged 0 | |
INGREDION INC | 200,000 | $21.7M | 0.2% | $74.34 | +38.71% | 18 qtrssince 2019-Q3 | Increased 41 | |
LYONDELLBASELL INDUSTRIES NV | 227,000 | $21.6M | 0.2% | $70.10 | +16.75% | 20 qtrssince 2019-Q1 | Increased 38 | |
ALLY FINL INC | 600,000 | $21M | 0.2% | $26.80 | +21.40% | 3 qtrssince 2023-Q2 | Increased 48 | |
APOLLO GLOBAL MGMT INC | 200,000 | $18.6M | 0.2% | $64.80 | +39.72% | 5 qtrssince 2022-Q4 | Increased 38 | |
META PLATFORMS INC | 50,000 | $17.7M | 0.2% | $192.94 | +82.18% | 15 qtrssince 2020-Q2 | Decreased 0 | |
HCA HEALTHCARE INC | 65,000 | $17.6M | 0.2% | $182.10 | +46.40% | 7 qtrssince 2022-Q2 | Increased 41 | |
GOLDMAN SACHS GROUP INC | 36,500 | $14.1M | 0.1% | $369.11 | 0.00% | 1 qtr | New 49 | |
Showing 10 of 18 results.8 more with Pro.PROUpgrade to see all → | ||||||||
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer